Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Genomic Vision SA (G09.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
0.0490-0.0026 (-5.04%)
At close: 04:44PM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
1,451
1,413
1,297
2,239
1,904
Cost of Revenue
439
606
789
967
327
Gross Profit
1,012
807
508
1,272
1,577
Operating Expense
6,135
5,705
5,626
5,494
7,971
Operating Income
-5,123
-4,898
-5,118
-4,222
-6,394
Net Non Operating Interest Income Expense
60
-71
-68
8
10
Pretax Income
-5,181
-4,961
-5,177
-4,608
-6,898
Tax Provision
-
37
-
-
-
Net Income Common Stockholders
-5,237
-4,998
-5,177
-4,608
-6,898
Diluted NI Available to Com Stockholders
-5,237
-4,998
-5,177
-4,608
-6,898
Basic EPS
-
-0.10
-0.11
-0.16
-0.81
Diluted EPS
-
-0.10
-0.11
-0.16
-0.81
Basic Average Shares
-
50,271
45,389
28,330
8,487
Diluted Average Shares
-
50,271
45,389
28,330
8,487
Total Operating Income as Reported
-5,091
-4,895
-5,153
-4,605
-6,897
Total Expenses
6,574
6,311
6,415
6,461
8,298
Net Income from Continuing & Discontinued Operation
-5,237
-4,998
-5,177
-4,608
-6,898
Normalized Income
-5,237
-4,998
-5,177
-4,229
-6,395
Interest Income
-
-
-
-
1
Interest Expense
67
71
31
2
-
Net Interest Income
60
-71
-68
8
10
EBIT
-5,114
-4,890
-5,146
-4,606
-6,394
EBITDA
-4,664
-
-
-
-
Reconciled Cost of Revenue
439
606
789
967
327
Reconciled Depreciation
214
231
589
78
1,043
Net Income from Continuing Operation Net Minority Interest
-5,237
-4,998
-5,177
-4,608
-6,898
Total Unusual Items Excluding Goodwill
-
-
-
-379
-503
Total Unusual Items
-
-
-
-379
-503
Normalized EBITDA
-4,664
-4,505
-4,159
-3,782
-4,848
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement